Equities

Amgen Inc

0R0T:LSE

Amgen Inc

  • Price (USD)313.50
  • Today's Change0.00 / 0.00%
  • Shares traded2.66k
  • 1 Year change41.06%
  • Beta--
Data delayed at least 20 minutes, as of May 17 2024 19:12 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Amgen Inc had little change in net income (from 6.55bn to 6.72bn) despite revenues that grew 7.09% from 26.32bn to 28.19bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 24.34% to 29.85%.
Gross margin66.38%
Net profit margin12.74%
Operating margin23.92%
Return on assets4.14%
Return on equity72.57%
Return on investment5.09%
More ▼

Cash flow in USDView more

In 2023, Amgen Inc increased its cash reserves by 43.45%, or 3.32bn. Cash Flow from Financing totalled 21.05bn or 74.66% of revenues. In addition the company generated 8.47bn in cash from operations while cash used for investing totalled 26.20bn.
Cash flow per share15.51
Price/Cash flow per share20.12
Book value per share9.36
Tangible book value per share-83.74
More ▼

Balance sheet in USDView more

Amgen Inc has a Debt to Total Capital ratio of 92.73%, a lower figure than the previous year's 1,136.14%.
Current ratio1.42
Quick ratio0.9793
Total debt/total equity12.75
Total debt/total capital0.9273
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)2.85%
Div growth rate (5 year)10.04%
Payout ratio (TTM)125.27%
EPS growth(5 years)-0.2187
EPS (TTM) vs
TTM 1 year ago		-52.46
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.